NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells

Free Radical Biology and Medicine

Volumn 51, Issue 6, 2011, Pages 1126-1136

  Cattaneo, Fabio ^a   Iaccio, Annalisa ^a   Guerra, Germano ^b   Montagnani, Stefania ^a   Ammendola, Rosario ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

c Src; EGFR; Formyl peptide receptors; Free radicals; NADPH oxidase; Reactive oxygen species; STAT3

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; APOCYNIN; FORMYLPEPTIDE RECEPTOR LIKE 1; PEPTIDE DERIVATIVE; PERTUSSIS TOXIN; PHOSPHOTYROSINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; STAT3 PROTEIN; STEROID RECEPTOR COACTIVATOR 1; TRYPTOPHYLARGINYLTRYPTOPHYLTRYPTOPHYLTRYPTOPHYLTRYPTOPHAN; TRYPTOPHYLLYSYLTYROSYLMETHIONYLVALYLMETHIONINE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ARTICLE; BINDING SITE; CANCER CELL; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULAR INTERACTION; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSACTIVATION;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MOLECULAR TARGETED THERAPY; NADPH OXIDASE; OLIGOPEPTIDES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PYRIMIDINES; REACTIVE OXYGEN SPECIES; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 80051798505     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.05.040     Document Type: Article

References (87)

1. E.R. Prossnitz, and R.D. Ye The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function Pharmacol. Ther. 74 1997 73 102 (Pubitemid 27337355)
2. Y. Le, J.J. Oppenheim, and J.M. Wang Pleiotropic roles of formyl peptide receptors Cytokine Growth Factor Rev. 12 2001 91 105 (Pubitemid 32294589)
3. Y. Le, P.M. Murphy, and J.M. Wang Formyl-peptide receptors revisited Trends Immunol. 23 2002 541 548 (Pubitemid 35223553)
4. M. Durstin, J.L. Gao, H.L. Tiffany, D. McDermott, and P.M. Murphy Differential expression of the N-formylpeptide receptor gene cluster in human phagocytes Biochem. Biophys. Res. Commun. 201 1994 174 179 (Pubitemid 24213710)
5. E.L. Becker, F.A. Forouhar, M.L. Grunnet, F. Boulay, M. Tardif, B.J. Bormann, D. Sodja, R.D. Ye, J.R. Woska Jr., and P.M. Murphy Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues and cells Cell Tissue Res. 292 1998 129 135 (Pubitemid 28143884)
6. M. Harada, Y. Habata, M. Hosoya, K. Nishi, R. Fujii, M. Kobayashi, and S. Hinuma N-formylated humanin activates both formyl peptide receptor-like 1 and 2 Biochem. Biophys. Res. Commun. 324 2004 255 261 (Pubitemid 39311487)
7. R. Ammendola, L. Russo, C. De Felice, F. Esposito, T. Russo, and F. Cimino Low-affinity receptor-mediated induction of superoxide by N-formyl-methionyl-leucyl-phenylalanine and WKYMVm in IMR90 human fibroblasts Free Radic. Biol. Med. 36 2004 189 200 (Pubitemid 38117237)
8. S.H. Baek, J.K. Seo, C.-B. Chae, P.G. Suh, and S.H. Ryu Identification of the peptides that stimulate the phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils J. Biol. Chem. 271 1996 8170 8175 (Pubitemid 26108645)
9. A. Iaccio, A. Angiolillo, and R. Ammendola Intracellular signaling triggered by formyl-peptide receptors in nonphagocytic cells Curr. Signal Transduct. Ther. 3 2008 88 96
10. A. Iaccio, F. Cattaneo, M. Mauro, and R. Ammendola FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblasts Arch. Biochem. Biophys. 481 2009 94 100
11. F. Cattaneo, G. Guerra, and R. Ammendola Expression and signaling of formyl peptide receptors in the brain Neurochem. Res. 35 2010 2018 2026
12. A. Fontayne, P.M. Dang, M.A. Goucerot-Pocidalo, and J. El Benna Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation Biochemistry 41 2002 7743 7750 (Pubitemid 34627801)
13. C. Dewas, M. Fay, M.A. Gougerot-Pocidalo, and J. El-Benna The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils J. Immunol. 165 2000 5238 5244
14. A.S. Lal, A.D. Clifton, J. Rouse, A.W. Segal, and P. Cohen Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38 Biochem. Biophys. Res. Commun. 259 1999 465 470 (Pubitemid 29281254)
15. T.L. Leto, S. Morand, D. Hurt, and T. Ueyama Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidase Antioxid. Redox Signal. 10 2009 2607 2619
16. G.M. Bokoch, B. Diebold, J.S. Kim, and D. Gianni Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases Antioxid. Redox Signal. 10 2009 2429 2441
17. B. Griffith, S. Pendyala, L. Hecker, P.L. Lee, and V. Natarajan Nox enzymes and pulmonary disease Antioxid. Redox Signal. 10 2009 2506 2516
18. R. Takeya, N. Ueno, K. Kami, M. Taura, M. Kohjima, T. Izaki, H. Nunoi, and H. Sumimoto Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases J. Biol. Chem. 278 2003 25234 25246 (Pubitemid 37548688)
19. J.D. Lambeth, T. Kawahara, and B. Diebold Regulation of Nox and Duox enzymatic activity and expression Free Radic. Biol. Med. 43 2007 319 331 (Pubitemid 46978416)
20. Y.-A. Suh, R.S. Arnold, B. Lassegue, J. Shi, X. Xu, D. Sorescu, A.B. Chung, K.K. Griendling, and J.D. Lambeth Cell transformation by the superoxide-generating oxidase Mox1 Nature 401 1999 79 82
21. B. Lassègue, D. Sorescu, K. Szöcs, Q. Yin, M. Akers, Y. Zhang, S.L. Grant, J.D. Lambeth, and K.K. Griendling Novel gp91phox homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways Circ. Res. 88 2001 888 894 (Pubitemid 32441466)
22. G. Cheng, and J.D. Lambeth NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain J. Biol. Chem. 279 2004 4737 4742 (Pubitemid 38199068)
23. D.I. Brown, and K.K. Griendling Nox proteins in signal transduction Free Radic. Biol. Med. 47 2009 1239 1253
24. N. Ueno, R. Takeya, K. Miyano, H. Kikuchi, and H. Sumimoto The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators J. Biol. Chem. 280 2005 23328 23339 (Pubitemid 40853246)
25. H.S. Park, H.Y. Jung, E.Y. Park, J. Kim, W.J. Lee, and Y.S. Bae Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B J. Immunol. 173 2004 3589 3593 (Pubitemid 39280716)
26. 2 and plays an integral role in insulin signal transduction Mol. Cell. Biol. 24 2004 1844 1854 (Pubitemid 38248927)
27. Y. Gorin, J.M. Ricono, N.H. Kim, B. Bhandari, G.G. Choudhury, and H.E. Abboud Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells Am. J. Physiol. Renal Physiol. 285 2003 F219 F229
28. R. Ammendola, M.R. Ruocchio, G. Chirico, L. Russo, C. De Felice, F. Esposito, T. Russo, and F. Cimino Inhibition of NADH/NADPH oxidase affects signal transduction by growth factor receptors in normal fibroblasts Arch. Biochem. Biophys. 397 2002 253 257 (Pubitemid 34852288)
29. A. Iaccio, C. Collinet, N. Montesano Gesualdi, and R. Ammendola Protein kinase C-α and -δ are required for NADPH oxidase activation in WKYMVm-stimulated IMR90 human fibroblasts Arch. Biochem. Biophys. 459 2007 288 294 (Pubitemid 46367842)
30. H. Daub, C. Wallasch, A. Lankenau, A. Herrlich, and A. Ullrich Signal characteristics of G protein-transactivated EGF receptor EMBO J. 23 1997 7032 7044 (Pubitemid 27520803)
31. A. Knebel, H.J. Rahmsdorf, A. Ullrich, and A. Herrlich Dephosphorylation of receptor tyrosine kinase as target of regulation by radiation, oxidants and alkylating agents EMBO J. 15 1996 5314 5325 (Pubitemid 26336214)
32. Z. Zhong, Z. Wen, and J.E. Darnell Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 Science 264 1994 95 98 (Pubitemid 24144493)
33. E.B. Haura, J. Turkson, and R. Jove Mechanisms of diseases: insight into the emerging role of signal transducers and activators of transcription in cancer Nat. Clin. Pract. Oncol. 2 2005 315 324 (Pubitemid 40903176)
34. D.E. Levy, and J.E. Darnell Jr. Stats: transcriptional control and biological impact Nat. Rev. Mol. Cell Biol. 3 2002 651 662 (Pubitemid 34987786)
35. H. Lo, H. Cheung, and Y.H. Wong Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK and ERK-dependent mechanism J. Biol. Chem. 278 2003 52154 52165 (Pubitemid 38035802)
36. H. Liang, V.J. Venema, X. Wang, H. Ju, R.C. Venema, and M.B. Marrero Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells J. Biol. Chem. 274 1999 19846 19851
37. J.J. Buggy Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway Biochem. J. 331 1998 211 216 (Pubitemid 28163976)
38. E.J. Jo, H.Y. Lee, J.I. Kim, H.-K. Kang, Y.-N. Lee, J.-Y. Kwak, and Y.-S. Bae Activation of formyl peptide receptor like-1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxide Life Sci. 75 2004 2217 2232 (Pubitemid 39127472)
39. E.H. Wu, R.K. Lo, and Y.H. Wong Regulation of STAT3 activity by G16-coupled receptors Biochem. Biophys. Res. Commun. 303 2003 920 925 (Pubitemid 36384943)
40. C. Bianco, G. Tortora, R. Bianco, R. Caputo, B.M. Veneziani, R. Caputo, V. Damiano, T. Troiani, G. Fontanini, D. Raben, S. Pepe, A.R. Bianco, and F. Ciardiello Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa) Clin. Cancer Res. 8 2002 3250 3258 (Pubitemid 35155038)
41. Y.K. Han, H.J. Moon, B.R. You, S.Z. Kim, S.H. Kim, and W.H. Park The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione Int. J. Mol. Med. 25 2010 657 662
42. Y.K. Han, H.J. Moon, B.R. You, S.Z. Kim, S.H. Kim, and W.H. Park The effect of MAPK inhibitors on arsenic trioxide-treated CaLu-6 lung cells in relation to cell death, ROS and GSH levels Anticancer Res. 29 2009 3837 3844
43. J. El-Benna, P.M. Dang, M.A. Gougerot-Pocidalo, J.C. Marie, and F. Braut-Boucher p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases Exp. Mol. Med. 41 2009 217 225
44. J. Huang, J. Hu, X. Bian, K. Chen, W. Gong, N.M. Dunlop, O.M. Howard, and J.M. Wang Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behaviour of human glioblastoma cells Cancer Res. 67 2007 906 5913
45. Y. Zhou, X. Bian, Y. Le, W. Gong, J. Hu, X. Zhang, L. Wang, P. Iribarren, R. Salcedo, O.M. Howard, W. Farrar, and J.M. Wang Formylpeptide receptor FPR and the rapid growth of malignant human gliomas J. Natl. Cancer Inst. 97 2005 823 835 (Pubitemid 40909125)
46. X.H. Yao, Y.F. Ping, J.H. Chen, D.L. Chen, C.P. Xu, J. Zheng, J.M. Wang, and X.W. Bian Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR J. Neurooncol 86 2008 47 53 (Pubitemid 350263431)
47. O.M. Fischer, S. Giordano, P.M. Comoglio, and A. Ullrich Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells J. Biol. Chem. 279 2004 28970 28978 (Pubitemid 38915766)
48. S. Catarzi, C. Biagioni, E. Giannoni, F. Favilli, T. Marcucci, T. Iantomasi, and M.T. Vincenzini Redox regulation of platelet-derived-growth- factor-receptor: role of NADPH oxidase and c-Src tyrosine kinase Biochim. Biophys. Acta 1745 2005 166 175 (Pubitemid 41207890)
49. Y.S. Bae, S.W. Kang, M.S. Seo, I.C. Baines, E. Tekle, P.B. Chock, and S.G. Rhee Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation J. Biol. Chem. 272 1997 217 221 (Pubitemid 27021147)
50. 2 for platelet-derived growth factor signal transduction Science 270 1995 296 299
51. O.M. Fischer, S. Hart, A. Gschwind, and A. Ullrich EGFR signal transactivation in cancer cells Biochem. Soc. Trans. 31 2003 1203 1208 (Pubitemid 38030939)
52. B.H. Shah, M.P. Farshori, A. Jambusaria, and K.J. Catt Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation J. Biol. Chem. 278 2003 10118 19126
53. L.M. Luttrell, G.J. Della Rocca, T. van Biesen, D.K. Luttrell, and R.J. Lefkowitz Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor: a scaffold for G protein-coupled receptor-mediated Ras activation J. Biol. Chem. 272 1997 4637 4644 (Pubitemid 27086335)
54. D. Bokemeyer, U. Schmitz, and H.J. Kramer Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor Kidney Int. 58 2000 549 558 (Pubitemid 30620004)
55. B.E. Slack The m3 muscarinic acetylcholine receptor is coupled to mitogen-activated protein kinase via protein kinase C and epidermal growth factor receptor kinase Biochem. J. 348 2000 381 387 (Pubitemid 30345212)
56. A.Y. Kam, T.T. Tse, D.H. Kwan, and Y.H. Wong Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-alpha in human U87 astrocytoma cells Cell. Signal. 19 2007 2106 2117 (Pubitemid 47354165)
57. I. Nakashima, M. Kato, A.A. Akhand, H. Suzuki, K. Takeda, K. Hossain, and Y. Kawamoto Redox-linked signal transduction pathways for protein tyrosine kinase activation Antioxid. Redox Signal. 4 2002 517 531 (Pubitemid 34753392)
58. Y.S. Bae, H.Y. Lee, E.J. Jo, J.I. Kim, H.K. Kang, R.D. Ye, J.Y. Kwak, and S.H. Ryu Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling J. Immunol. 173 2004 607 614 (Pubitemid 38797390)
59. C.M. Silva Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis Oncogene 23 2004 8017 8023 (Pubitemid 39468859)
60. S. D'Alessio, and F. Blasi The urokinase receptor as an entertainer of signal transduction Front. Biosci. 14 2009 4575 4587
61. J. Chung, E. Uchida, T.C. Grammer, and J. Blenis STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation Mol. Cell. Biol. 17 1997 6508 6516 (Pubitemid 27451197)
62. J.S. Newton Angiotensin and epidermal growth factor receptor cross talk goes up and down J. Hypertens. 20 2002 597 598 (Pubitemid 34913697)
63. Y. Zhao, D. He, B. Saatian, T. Watkins, E.W. Spannhake, N.J. Pyne, and V. Natarajan Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases J. Biol. Chem. 281 2006 19501 19511 (Pubitemid 44035454)
64. C. Porcile, A. Bajetto, F. Barbieri, S. Barbero, R. Bonavia, M. Biglieri, P. Pirani, T. Florio, and G. Schettini Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation Exp. Cell Res. 308 2005 241 253
65. J. Madarame, S. Higashiyama, H. Kiyota, A. Madachi, F. Toki, T. Shimomura, N. Tani, Y. Oishi, and N. Matsuura Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin Prostate 57 2003 187 195 (Pubitemid 37267803)
66. S.M. Vaingankar, and M. Martins-Green Thrombin activation of the 9E3/CEF4 chemokine involves tyrosine kinases including c-src and the epidermal growth factor receptor J. Biol. Chem. 273 1998 5226 5234 (Pubitemid 28108686)
67. F. Vacca, A. Bagnato, K.J. Catt, and R. Tecce Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells Cancer Res. 60 2000 5310 5317
68. J. Huang, K. Chen, W. Gong, Y. Zhou, Y. Le, X. Bian, and J.M. Wang Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression Cancer Lett. 267 2008 254 261
69. N. Prenzel, E. Zwick, H. Daub, M. Leserer, R. Abraham, C. Wallasch, and A. Ullrich EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 1999 884 888
70. F.S. Lee, and M.V. Chao Activation of Trk neurotrophin receptors in the absence of neurotrophins Proc. Natl Acad. Sci. U. S. A. 98 2001 3555 3560 (Pubitemid 32220883)
71. T. Tanimoto, Z.G. Jin, and B.C. Berk Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS) J. Biol. Chem. 277 2002 42997 43001 (Pubitemid 35285679)
72. M. Ushio-Fukai, K.K. Griendling, P.L. Becker, L. Hilenski, S. Halleran, and R.W. Alexander Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 21 2001 489 495 (Pubitemid 32323378)
73. Y. Saito, and B.C. Berk Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors J. Mol. Cell. Cardiol. 33 2001 3 7 (Pubitemid 32127779)
74. S.G. Rhee, S.W. Kang, W. Jeong, T.S. Chang, K. Yang, and H.A. Woo Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins Curr. Opin. Cell Biol. 17 2005 183 189 (Pubitemid 40380942)
75. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189 (Pubitemid 38339084)
76. B. Lassègue, and R.E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 2003 R277 R297
77. J.D. Lambeth Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy Free Radic. Biol. Med. 43 2007 332 347 (Pubitemid 46992767)
78. F.D. Oakley, D. Abbott, Q. Li, and J.F. Engelhardt Signaling components of redox active endosomes: the redoxosomes Antioxid. Redox Signal. 11 2009 1313 1333
79. D. Gianni, B. Bohl, S.A. Courtneidge, and G.M. Bokoch The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1 Mol. Biol. Cell 19 2008 2984 2994
80. H. Kim, J.H. Park, E.-H. Lee, M.-J. Kim, S.K. Park, S.-K. Heo, B.-S. Kim, and Y.J. Min Granulocyte function is stimulated by a novel hexapeptide, WKYMVm, in chemotherapy-treated cancer patients Exp. Hematol. 34 2006 407 413
81. C. Lin, W. Wei, J. Zhang, S. Liu, Y. Liu, and D. Zheng Formyl peptide receptor-like 1-mediated endogenous TRAIL gene expression with tumoricidal activity Mol. Cancer Ther. 6 2007 2618 2625 (Pubitemid 350058142)
82. S.D. Kim, Y.K. Kim, H.Y. Lee, Y.S. Kim, S.G. Jeon, S.H. Baek, D.K. Song, S.H. Ryu, and Y.S. Bae The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection J. Immunol. 185 2010 4302 4310
83. B.Q. Li, M.A. Wetzel, J.A. Mikovits, E.E. Henderson, T.J. Rogers, W. Gong, Y. Le, F.W. Ruscetti, and J.M. Wang The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1 Blood 97 2001 2941 2947
84. F.N. Gavins Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol. Sci. 31 2010 266 276
85. Y. Le, Y. Yang, Y. Cui, H. Yazawa, W. Gong, C. Qiu, and J.M. Wang Receptors for chemotactic formyl peptides as pharmacological targets Int. Immunopharmacol. 2 2002 1 13 (Pubitemid 33086799)
86. C. Zhou, S. Zhang, M. Nanamori, Y. Zhang, Q. Liu, N. Li, M. Sun, J. Tian, P.P. Ye, N. Cheng, R.D. Ye, and M.W. Wang Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1 Mol. Pharmacol. 72 2007 976 983 (Pubitemid 47481420)
87. J. Huang, K. Chen, J. Chen, W. Gong, N.M. Dunlop, O.M. Howard, Y. Gao, X.W. Bian, and J.M. Wang The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells Br. J. Cancer 102 2010 1052 1060